Hemogenyx Pharmaceuticals Plc (HEMO.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 25.41M |
| Enterprise Value | 25.83M |
| P/E Ratio | -3.43 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 9.23 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.38 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.65 |
| Return On Equity | -4.1 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -588,753 |
| EBITDA | -4.07M |
| Net Income | -9.76M |
| Diluted EPS | -2.2 |
Balance Sheet
| Total Cash | 4.58M |
| Total Cash/Share | 0.71 |
| Total Debt | 1.85M |
| Total Debt/Equity | 0.43 |
| Current Ratio | 4.04 |
| Book Value Per Share | 0.66 |
Price History
| 52-Week Change | -28.74 |
| 52-Week High | 1,220 |
| 52-Week Low | 356 |
| Moving Average 50 Days | 581.19 |
| Moving Average 200 Days | 752.15 |
Statistics
| Average Volume | 23,431 |
| Shares Outstanding | 6.9M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:400 |
| Last Split Date | December 13, 2024 |
AD
